Clinical Management of Cancer Cachexia

This 2021 ESMO Clinical Practice Guideline provides healthcare professionals with a concise and evidence-based overview of how to assess and manage cancer cachexia, a complex metabolic syndrome characterized by involuntary weight loss, muscle wasting, and systemic inflammation. It outlines the key criteria used to diagnose cachexia and emphasizes early identification, nutritional support, and multimodal intervention. Drawing from international oncology and palliative care expertise, this guideline offers step-by-step recommendations for screening, intervention planning, and symptom control, ensuring that cancer patients receive timely and holistic support to preserve their function and quality of life.

Why It Matters in Your Day-to-Day Practice

This guideline is an essential tool for HCPs in oncology, clinical nutrition, palliative care, and rehabilitation medicine. By engaging with this publication, you'll gain:

• Clarity on cachexia diagnosis and progression stages

• A structured approach to nutritional and physical screening

• Evidence-based guidance on pharmacological treatments and exercise

• Strategies to personalize interventions across tumour types and care settings

Download Now and Expand Your Knowledge

Click on “View Content” to access a trusted source and download the ESMO Clinical Practice Guideline. Deepen your understanding of cancer cachexia and strengthen your care approach with evidence-based tools, decision pathways, and multidisciplinary strategies.

More recommendations, clinical data, and treatment insights are available in the full resource.